An observational study to determine T-cell responses to neoantigens following treatment with ipilimumab in men with metastatic castration-resistant prostate carcinoma - Stand Up To Cancer

Blog

Posted October 14, 2019

An observational study to determine T-cell responses to neoantigens following treatment with ipilimumab in men with metastatic castration-resistant prostate carcinoma

JOIN OUR COMMUNITY

Sign up to receive emails from Stand Up To Cancer.
   Please leave this field empty
Stand Up to Cancer

Thanks for signing up!
You will hear from us soon.